Edition:
India

Catalent Inc (CTLT.N)

CTLT.N on New York Stock Exchange

42.81USD
21 Feb 2018
Change (% chg)

$0.33 (+0.78%)
Prev Close
$42.48
Open
$42.51
Day's High
$44.00
Day's Low
$42.51
Volume
234,827
Avg. Vol
298,130
52-wk High
$47.86
52-wk Low
$27.48

Chart for

About

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of... (more)

Overall

Beta: --
Market Cap(Mil.): $5,305.52
Shares Outstanding(Mil.): 125.46
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-Catalent Announces Changes To Its Board Of Directors

* CATALENT - ANNOUNCED ADDITION OF 3 NEW MEMBERS TO BOARD AND RETIREMENT OF BOARD MEMBER JAMES QUELLA

20 Feb 2018

BRIEF-Catalent Posts Q2 Loss Per Share $0.16

* QTRLY ‍REVENUE OF $606.3 MILLION INCREASED 25% AS-REPORTED, OR 22 PCT IN CONSTANT CURRENCY FROM PRIOR-YEAR PERIOD​

05 Feb 2018

BRIEF-Catalent Q1 earnings per share $0.03

* Q1 earnings per share view $0.17 -- Thomson Reuters I/B/E/S

06 Nov 2017

BRIEF-Catalent completes repricing and extension of credit agreement

* Catalent completes repricing and extension of credit agreement Source text for Eikon: Further company coverage:

19 Oct 2017

BRIEF-Catalent announces pricing of private offering of senior unsecured notes due 2026

* Catalent announces pricing of private offering of senior unsecured notes due 2026

16 Oct 2017

BRIEF-Catalent launches private offering of $450 mln of senior unsecured notes due 2026

* Catalent announces launch of private offering of $450 million of senior unsecured notes due 2026

10 Oct 2017

BRIEF-Catalent Inc announces pricing of public offering

* Catalent Inc announces pricing of public offering of common stock to fund part of its acquisition of Cook Pharmica

27 Sep 2017

BRIEF-Catalent announces public offering of common stock to fund part of its acquisition of Cook Pharmica

* Catalent Inc announces public offering of common stock to fund part of its acquisition of Cook Pharmica

26 Sep 2017

BRIEF-Catalent files for common stock offering of upto $‍​250 million

* Catalent Inc - files for common stock offering of upto $‍​250.0 million- SEC Filing Source text:(http://bit.ly/2xGCzV4) Further company coverage:

26 Sep 2017

Catalent bolsters biopharma business with Cook Pharmica buy

U.S. drug contract manufacturer Catalent Inc agreed to buy Cook Pharmica LLC for $950 million in cash as the company doubles down on its fast-growing business of supplying biologics to drugmakers.

19 Sep 2017

Earnings vs. Estimates